Literature DB >> 27189373

Prevalence of Anxiety and Depression in Pulmonary Hypertension and Changes during Therapy.

Gina Somaini1, Elisabeth D Hasler, Stéphanie Saxer, Lars C Huber, Mona Lichtblau, Rudolf Speich, Konrad E Bloch, Silvia Ulrich.   

Abstract

BACKGROUND: Pulmonary hypertension (PH) leads to reduced health-related quality of life (HRQoL).
OBJECTIVE: To investigate the prevalence and course of anxiety and depression and their association with HRQoL, disease severity and survival in PH.
METHODS: 131 PH patients (91 pulmonary arterial, 30 chronic thromboembolic, 10 due to lung disease; 84 female, 47 male) had repeated assessments with the Hospital Anxiety and Depression Scale (HADS), HRQoL, six-minute walk distance and WHO functional class during a mean course of 16 ± 12 months.
RESULTS: Among the 49 incident and 82 prevalent PH patients, the HADS score was positive in 53%/21% (depression), 51%/24% (anxiety) and 63%/26% (total score) (all p < 0.05). The HADS score was improved at the second assessment in incident patients. The HADS score correlated with HRQoL at all consecutive assessments and with functional class until the third assessment, but not with baseline hemodynamics, age or gender.
CONCLUSION: Mood disorders remain underdiagnosed in PH. The higher prevalence of anxiety/depression in incident versus prevalent patients and the improvement over time may indicate an amelioration of mood disorders after PH diagnosis and treatment.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27189373     DOI: 10.1159/000445805

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  10 in total

Review 1.  Anxiety and depression in patients with pulmonary hypertension: impact and management challenges.

Authors:  Maurizio Bussotti; Marinella Sommaruga
Journal:  Vasc Health Risk Manag       Date:  2018-11-08

2.  Exploring the experiences and psychosocial stresses of Taiwanese patients with pulmonary hypertension: a qualitative interview study.

Authors:  Yung-Chih Chiang; Li-Yu Hu; Jeremy Couper; Chin-Chang Cheng; Ling-Hsiang Wang; Wei-Chun Huang; Ti Lu
Journal:  Pulm Circ       Date:  2018-06-19       Impact factor: 3.017

3.  Supervised pulmonary hypertension exercise rehabilitation (SPHERe): study protocol for a multi-centre randomised controlled trial.

Authors:  Gordon McGregor; Julie Bruce; Stuart Ennis; James Mason; Ranjit Lall; Chen Ji; Harbinder Sandhu; Kate Seers; Prithwish Banerjee; Alastair Canaway; Katie Booth; Stephanie J C Taylor; Elizabeth Robertson; Tamar Pincus; Sally Singh; David Fitzmaurice; Sarah Bowater; Paul Clift; Martin Underwood
Journal:  BMC Pulm Med       Date:  2020-05-19       Impact factor: 3.317

4.  Association of daily physical activity with psychosocial aspects and functional capacity in patients with pulmonary arterial hypertension: a cross-sectional study.

Authors:  Layse Nakazato; Felipe Mendes; Ilma A Paschoal; Daniela C Oliveira; Marcos M Moreira; Mônica C Pereira
Journal:  Pulm Circ       Date:  2021-03-29       Impact factor: 3.017

5.  Depression, anxiety and psychological distress in patients with pulmonary hypertension: a mixed-methods study.

Authors:  Yuka Takita; Yuko Takeda; Daisuke Fujisawa; Masaharu Kataoka; Takashi Kawakami; Ardith Z Doorenbos
Journal:  BMJ Open Respir Res       Date:  2021-04

6.  Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study.

Authors:  Laurence Halimi; Carey M Suehs; Gregory Marin; Clement Boissin; Anne-Sophie Gamez; Isabelle Vachier; Nicolas Molinari; Arnaud Bourdin
Journal:  ERJ Open Res       Date:  2021-08-23

7.  Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis.

Authors:  Aaron Shengting Mai; Oliver Zi Hern Lim; Yeung Jek Ho; Gwyneth Kong; Grace En Hui Lim; Cheng Han Ng; Cyrus Ho; Roger Ho; Yinghao Lim; Ivandito Kuntjoro; Edgar Tay; James Yip; Nicholas W S Chew; Ting-Ting Low
Journal:  Front Med (Lausanne)       Date:  2022-02-17

8.  Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension.

Authors:  Flora Caldarone; Philippa Gebhardt; Marius M Hoeper; Karen M Olsson; Jan Fuge; Da-Hee Park; Tanja Meltendorf; Jan C Kamp; Britta Stapel; Manuel J Richter; Henning Gall; Hossein A Ghofrani; Kai G Kahl; Ivo Heitland
Journal:  Front Psychiatry       Date:  2022-04-14       Impact factor: 4.157

9.  Physical Activity in Pulmonary Arterial Hypertension during Pandemic COVID-19 and the Potential Impact of Mental Factors.

Authors:  Maria Wieteska-Miłek; Sebastian Szmit; Michał Florczyk; Anna Witowicz; Marcin Kurzyna
Journal:  Int J Environ Res Public Health       Date:  2022-07-08       Impact factor: 4.614

10.  Anxiety, Depression and Quality of Life in Pulmonary Hypertension: A Comparison of Incident and Prevalent Cases.

Authors:  Elena Pfeuffer-Jovic; Franziska Joa; Michael Halank; Jens-Holger Krannich; Matthias Held
Journal:  Respiration       Date:  2022-04-27       Impact factor: 3.966

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.